Oxcarbazepine Adjunctive Therapy for Partial Seizures

Authors

  • J Gordon Millichap Northwestern University Feinberg School of Medicine

DOI:

https://doi.org/10.15844/pedneurbriefs-14-7-6

Keywords:

Oxcarbazepine, Adjunctive Antiepileptic Therapy, Placebo-Controlled Trial

Abstract

The safety and efficacy of oxcarbazepine (OXC) as adjunctive therapy for refractory partial seizures were evaluated in 267 patients in a multicenter (47 centers in 8 countries; Argentina, Chile, Uruguay, Australia, New Zealand, Canada, Israel, and the USA), randomized, placebo-controlled trial, and reported from the Children’s Hospital, Cincinnati, OH.

Published

2000-07-01

Issue

Section

Antiepileptic Medications